Toggle Main Menu Toggle Search

Open Access padlockePrints

The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time

Lookup NU author(s): Professor James Shaw, Dr Bill ScottORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Copyright © 2023 Piemonti, Scholz, de Jongh, Kerr-Conte, van Apeldoorn, Shaw, Engelse, Bunnik, Mühlemann, Pal-Kutas, Scott, Magalon, Kugelmeier and Berishvili.The field of transplantation has witnessed the emergence of Advanced Therapy Medicinal Products (ATMPs) as highly promising solutions to address the challenges associated with organ and tissue transplantation. ATMPs encompass gene therapy, cell therapy, and tissue-engineered products, hold immense potential for breakthroughs in overcoming the obstacles of rejection and the limited availability of donor organs. However, the development and academic research access to ATMPs face significant bottlenecks that hinder progress. This opinion paper emphasizes the importance of addressing bottlenecks in the development and academic research access to ATMPs by implementing several key strategies. These include the establishment of streamlined regulatory processes, securing increased funding for ATMP research, fostering collaborations and partnerships, setting up centralized ATMP facilities, and actively engaging with patient groups. Advocacy at the policy level is essential to provide support for the development and accessibility of ATMPs, thereby driving advancements in transplantation and enhancing patient outcomes. By adopting these strategies, the field of transplantation can pave the way for the introduction of innovative and efficacious ATMP therapies, while simultaneously fostering a nurturing environment for academic research.


Publication metadata

Author(s): Piemonti L, Scholz H, de Jongh D, Kerr-Conte J, van Apeldoorn A, Shaw JAM, Engelse MA, Bunnik E, Muhlemann M, Pal-Kutas K, Scott WE, Magalon J, Kugelmeier P, Berishvili E

Publication type: Article

Publication status: Published

Journal: Transplant International

Year: 2023

Volume: 36

Online publication date: 27/09/2023

Acceptance date: 12/09/2023

Date deposited: 02/11/2023

ISSN (print): 0934-0874

ISSN (electronic): 1432-2277

Publisher: European Society for Organ Transplantation

URL: https://doi.org/10.3389/ti.2023.11633

DOI: 10.3389/ti.2023.11633

Data Access Statement: Publicly available datasets were analyzed in this study. This data can be found here: European Medicines Agency. CAT Quarterly Highlights and Approved ATMPs - January 2023 (2023). Available from: https://www.ema.europa.eu/en/documents/report/cat-quarterly-highlights-approved-atmps-january-2023_en.pdf (Accessed September 22, 2023).

PubMed id: 37822447


Altmetrics

Altmetrics provided by Altmetric


Share